Depression is a serious medical condition and is a leading cause of disability worldwide.
Current depression diagnostics and assessment has significant limitations due to …

Major Depressive disorder (MDD) manifests by dysphoria, anhedonia, sleep disturbances,
poor concentration, fatigue, hopelessness, and suicidality [1]. MDD is highly prevalent …

Attention-deficit hyperactivity disorder (ADHD) is frequently comorbid with anxiety disorders
with rates as high as 25% to 50% in children and adolescents. Despite various treatment …

Buprenorphine is a safe and effective treatment for opioid use disorder but remains underutilized
because a major challenge of conventional buprenorphine initiation (termed induction) …

Cigarette smoking is the leading cause of preventable deaths, with more than 1 billion
tobacco smokers worldwide. 1, 2 This number has remained stagnant since 20071 despite …

To the Editor: Opioid use disorder (OUD) remains an important cause of morbidity and
mortality in the United States. 1 OUD is a chronic and relapsing condition, 2 with patients …

A pilot comparison of the safety and efficacy of methylphenidate (MPH) combined with
clonidine, clonidine monotherapy, or MPH monotherapy in 6to 16-year-old children diagnosed …

Attention-deficit/hyperactivity disorder (ADHD) presents in childhood with inattention, hyperactivity,
and impulsivity and is associated with functional impairments. These children tend to …

Objective. This report describes goals parents have for their children with attention deficit/hyperactivity
disorder (ADHD) when coming for a pediatric visit. Method. Data were collected …

Attention deficit hyperactivity disorder (ADHD) is a condition typically arising in childhood,
which untreated, can have consequences reaching into adolescence and beyond. Effective …